Home / Publications / The Stetter reaction: modern methodologies and useful applications in total synthesis of natural products and drugs

The Stetter reaction: modern methodologies and useful applications in total synthesis of natural products and drugs

1 Government College University Faisalabad, Pakistan
Published 2026-01-20received 2025-08-02
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Nawaz A., Zahoor A. F. The Stetter reaction: modern methodologies and useful applications in total synthesis of natural products and drugs // Russian Chemical Reviews. 2026. Vol. 95. No. 1. RCR5195
GOST all authors (up to 50) Copy
Nawaz A., Zahoor A. F. The Stetter reaction: modern methodologies and useful applications in total synthesis of natural products and drugs // Russian Chemical Reviews. 2026. Vol. 95. No. 1. RCR5195
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.59761/RCR5195
UR - https://rcr.colab.ws/publications/10.59761/RCR5195
TI - The Stetter reaction: modern methodologies and useful applications in total synthesis of natural products and drugs
T2 - Russian Chemical Reviews
AU - Nawaz, Ayesha
AU - Zahoor, Ameer Fawad
PY - 2026
DA - 2026/01/20
PB - ANO Editorial Board of the journal Uspekhi Khimii
SP - RCR5195
IS - 1
VL - 95
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2026_Nawaz,
author = {Ayesha Nawaz and Ameer Fawad Zahoor},
title = {The Stetter reaction: modern methodologies and useful applications in total synthesis of natural products and drugs},
journal = {Russian Chemical Reviews},
year = {2026},
volume = {95},
publisher = {ANO Editorial Board of the journal Uspekhi Khimii},
month = {Jan},
url = {https://rcr.colab.ws/publications/10.59761/RCR5195},
number = {1},
doi = {10.59761/RCR5195}
}
MLA
Cite this
MLA Copy
Nawaz, Ayesha, and Ameer Fawad Zahoor. “The Stetter reaction: modern methodologies and useful applications in total synthesis of natural products and drugs.” Russian Chemical Reviews, vol. 95, no. 1, Jan. 2026, p. RCR5195. https://rcr.colab.ws/publications/10.59761/RCR5195.
Views / Downloads
5 / 3

Keywords

asymmetric Stetter reaction
Breslow intermediate
natural products synthesis
Stetter reaction
Stetter-type reaction

Abstract

The Stetter reaction, a powerful umpolung strategy catalyzed by nucleophilic carbenes, enables the formation of 1,4-dicarbonyl compounds through the conjugate addition of aldehydes to Michael acceptors. Since its discovery in the 1970s, this reaction has evolved through thiazolium, triazolium, and many more catalysts, and more recently, with chiral N-heterocyclic carbenes for asymmetric applications. This review explores modern advances in the Stetter reaction under green conditions, enzyme catalysis, photochemical activation, and ball-milling techniques. It integrates recent advances in green chemistry, solvent-free systems, and biocatalytic processes while correlating them with applications in the total synthesis of natural products and pharmaceuticals. Particular focus is placed on the evolution of chiral NHCs, artificial Stetterases, and photoinduced pathways, which expand the reaction′s utility in asymmetric and sustainable synthesis. These methodologies highlight the reaction′s versatility in constructing complex compounds, its environmental compatibility via aqueous or solvent-free conditions, and its expanding role in medicinal chemistry.

The bibliography includes 140 references.

1. Introduction

Name reactions are well-known chemical transformations named after their discoverers; they are important because they simplify complex syntheses and save time by providing proven, predictable reaction pathways.[1-3] The Stetter reaction is an umpolung (polarity inversion) reaction between an aldehyde and α,β-unsaturated compound yielding 1,4-addition products, catalyzed by a nucleophilic catalyst. In 1973, Stetter and Schreckenberg[4] first described the umpolung process catalyzed by cyanide ions, which involved the reaction of aldehydes with Michael acceptors such as α,β-unsaturated ketones, esters, nitro compounds, and nitriles. In 1976, Stetter synthesized 1,4-dicarbonyl products through thiazolium-catalyzed reactions between aldehydes and Michael acceptors. Later, this reaction was named in his honor — the ‘Stetter reaction’. The thiazolium-catalyzed approach covers a variety of aromatic and aliphatic aldehydes 1 with Michael acceptors 2 to produce 1,4-addition products 3 with high selectivity (Scheme 1).[5][6] A wide variety of substrates, including diversely substituted benzoins, α,β-unsaturated esters, various aldehydes, including aliphatic, aromatic and heteroaromatic, ketones, nitriles, and nitro derivatives can all be utilized as appropriate Michael acceptors in the Stetter reaction.[7-10] A wide range of N-heterocyclic carbene (NHC)-based catalysts, e.g., thiazolium, triazolium and imidazolium carbenes are often effective catalysts to umpolung the aldehydes in the Stetter reaction.[11-13]

Scheme 1

An acceptable mechanism for the Stetter reaction includes deprotonation of the thiazolium salt C1 with the base followed by it conversion into the free carbene C1. Thiazolium carbene C1 reacts with an aldehyde 1 to give a tetrahedral intermediate Int 1, which transforms into nucleophilic Breslow intermediate Int 2 (enaminol) by 1,2-proton shift.[14] In 1958, Ronald Breslow[14] first proposed the intermediates produced in all thiamine-catalyzing reactions. Breslow intermediate Int 2 undergoes an irreversible addition to the Michael acceptor to generate intermediate Int 3, which converts into intermediate Int 4 by 1,4-proton shift, and then, after the release of free carbene C1, provides 1,4-dicarbonyl compound 3 (Scheme 2) or other derivatives like nitro-ketones,[10] ketophosphonates,[15] or keto-nitriles.[16] Alternative approaches included aza-Stetter reaction, producing aza-Breslow intermediate by imine umpolung[17] or sila-Stetter reaction, producing Breslow intermediate from acylsilanes.[7]

Scheme 2

In 1995, Ciganek[18] reported the first intramolecular Stetter reaction. The first enantioselective intramolecular Stetter reaction was explained by Enders et al.[19] Later, enantioselective 1,4-bifunctional compounds were synthesized by asymmetric transformation using chiral NHCs as a catalyst. In 2002, Rovis and co-workers[20] prepared the most effective aminoindanol-substituted chiral triazolium NHC precatalyst for the enantioselective intramolecular Stetter reaction using amino indanol (Scheme 3).

Scheme 3

In addition, Enders et al.[21] carried out the first intermolecular Stetter reaction between α,β-unsaturated aldehydes and chalcones, using a chiral thiazolium salt C'4 as a catalyst. Liu and Rovis[22] contributed to the asymmetric intermolecular Stetter reaction using glyoxamide moieties as an aldehyde component and alkylidene molecules as Michael acceptors. DiRocco and Rovis[23] used a fluorinated triazolium salt as a catalyst in the intermolecular Stetter reaction between β-nitroarene as a Michael acceptor and α,β-unsaturated aldehyde (Scheme 4).

Scheme 4

The synthesis of natural products is very important because it provides an access to valuable bioactive compounds that are difficult to obtain from nature.[24-26] It also helps in developing new biological active compounds[27-29] and understanding complex biological processes. Synthetically essential 1,4-di­carbonyl compounds and their derivatives are produced by the Stetter reaction making it a versatile, adaptable, practical, and efficient method for synthesizing complex chemical compounds, including natural products like trans-sabiene hydrate 14,[30] dihydrojasmone 15, cis-jasmone 16,[31] and (+)-monomorine I 17,[32] hirsutic acid C 18,[33] (–)-vallesamidine 19,[34] and englerin A 20,[35] as well as non-natural products like atorvastatin 21[36] and haloperidol 22[37] with potential medical applications. The Stetter reaction was also used to obtain the 1,4-diketone, intermediate compound in the synthesis of the product marketed under the brand name Lipitor (atorvastatin), and this modification was applied at the industrial level.[36][38]

Structures 14 – 22

In 2020, Heravi et al.[39] reviewed advancements in the Stetter reaction and its applications in the synthesis of natural products and heterocyclic compounds. In 2022, Shneine et al.[40] discussed different developments in the Stetter reaction. To date, many advancements have been reported concerning the Stetter reaction. This review covers recent (2020 – 2025) methodological approaches and syntheses of natural products and drugs via the Stetter reaction and offers an in-depth discussion of the Stetter reaction from both a mechanistic and practical perspectives. While earlier reviews mainly focused on classical NHC-catalyzed versions or specific reaction types, herein, organocatalytic, enzymatic, photochemical, and mechano­chemical approaches to the Stetter reaction are summarized. In addition, traditional solvent-based methods with emerging green and sustainable protocols, highlighting their relative advantages and limitations are compared. Furthermore, the industrial relevance and future potential of the Stetter reaction are emphasized, providing a clearer view of how this transformation can be adapted for large-scale and environmentally friendly chemical syntheses.

2. Methodological approach

[]

2.1. Green conditions for the Stetter reaction

Green chemistry focuses on designing chemical processes that reduce waste and minimize the use of hazardous substances. It promotes safer, energy-efficient, and environmentally friendly methods for producing useful compounds.[41] In 2022, Phungpis and Worawut[42] reported a novel ‘green’ modification of an intermolecular Stetter reaction efficiently between aromatic aldehydes 23 and acrylonitrile/methyl vinyl ketone/ethyl acrylate 24 in the presence of NaOH and the greenest solvent (water) at 100°C catalyzed by N,N-dimethylbenzimidazolium iodide C'7 (Scheme 5). Under optimal conditions, reactions between aldehydes 23 and a,b-unsaturated compounds 24a,b produced 1,4-addition products 25a – f,j',k' in 70 – 77% along with minor acyloin derivatives 26a – d as by-products. But with a less electrophilic double bond in ethyl acrylate 24c, the Breslow intermediate reacted more readily with more reactive aldehydes 23, despite ethyl acrylate 24, which produced high yields of acyloin derivatives 26a – d and moderate yields of 1,4-addition products 25g – i,l' (58 – 66%).

Scheme 5

According to the proposed mechanism of the Stetter reaction, NaOH deprotonates N,N-dimethylbenzimidazolium iodide C'7 to yield carbene C7, which then reacts with aldehyde 23 to produce the intermediate Int 5, as previously suggested (Scheme 6).[43] After 1,2-proton transfer, intermediate Int 5 transforms into Breslow intermediate Int 6. Then, intermediate Int 6 nucleophilically attacks Michael acceptors 24 to produce the tetrahedral intermediate Int 7. The water-mediated 1,4-proton transfer degenerates the tetrahedral intermediate Int 7 to intermediate Int 8, which then gives 1,4-addition products 25a – l and leads to regeneration of the carbene catalyst C7. The use of NaOH provides useful benefits including high basicity, reusability, and simple separation from the products. Furthermore, with a constant yield of 65%, the benzimidazolium salt and NaOH may be employed in at least four more reactions. An efficient and environmentally friendly method for synthesizing 1,4-addition products by the Stetter reaction showcases the potential for practical applications in organic synthesis. The use of water as a solvent and the ability to recycle the catalyst align with principles of green chemistry, emphasizing sustainability in chemical processes.

Scheme 6

In 2020, Debiais et al.[44] reported the first bio-inspired NHC-catalyzed Stetter reaction between aldehyde 1 and chalcone 7 in water, which imitated the thiamine diphosphate (vitamin B1) cofactor essential for biochemical processes. The authors analyzed the Stetter reaction, catalyzed by thiazolium salts C'1, C'8 – C'12 as thiamine analogues, and revealed that water promoted the formation of benzoin as a side product compared to reactions carried out in an organic solvent (THF). The Stetter reaction catalyzed by thiazolium salt C'10 in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and water at 75°C for 20 h, exhibited the highest efficiency, achieving 30 – 90% conversion mainly of the 1,4-diketone products 27a – i (Scheme 7). The substrate scope of the reaction was successfully extended to various aldehydes, and the effect of solvent and temperature on product selectivity was investigated. Lower temperatures are more appropriate for biomolecule compatibility; however, higher temperatures speed up the process. These findings inspired the synthesis of more lipophilic thiazolium salts C'11 and C'12; their efficiency was compared with that of salt C'10. Catalyst C'10 demonstrated the highest performance, achieving conversion up to 90% in water at 75°C, indicating excellent catalytic efficiency under aqueous conditions. In contrast, catalysts C'11 and C'12 showed moderate to lower activities. Overall, catalyst C' 8 significantly outperformed the other ones making it the most effective for the bio-inspired NHC-catalyzed Stetter reaction in aqueous media.

Scheme 7
Structures C'1, C'8 – C'12

The reaction is initiated by the deprotonation of precatalyst thiazolium salt C'10 to form the reactive NHC catalyst C10, which then reacts with benzoin 28 to yield the intermediate Int 9 (Scheme 8). Then, intermediate Int 9 is converted into intermediate Int 10 by the 1,4-proton shift promoted by H2O shown in intermediate Int 11. After that, intermediate Int 11 eliminates aldehyde 1 to give the Breslow intermediate Int12, which nucleophically reacts with Michael acceptor 7 to give intermediate Int 13. The intermediate Int 13 transforms into intermediate Int 14 via the 1,4-proton shift and finally affords the 1,4-addition product 27a – i, regenerating catalyst C10. According to the study, although Breslow intermediates were generated more rapidly in water, the rate-limiting step shifted from proton transfer to the retrobenzoin reaction, thereby reducing overall kinetics. To examine this effect, benzoin was used as a masked aldehyde, and the retrobenzoin route was found to be realized slower in water due to the formation of H-bonded solvated species (see Scheme 8). The reaction in water produced a heterogeneous emulsion, indicating a catalytic mechanism in which the formation of hydrophobic droplets affected reactivity. The efficiency of the process was depended on this environment, which shielded important Breslow intermediates confined in hydrophobic pockets of enzymes. The study aligns with green chemistry principles by demonstrating an organocatalytic reaction in water, thereby reducing the use of harmful solvents. It provided valuable mechanistic insights, optimizing efficiency and expanding the reaction scope for biomolecules and synthetic applications. The findings laid the groundwork for future research in the development of catalysts and bioconjugation techniques. While aqueous media are eco-friendly, solubility issues and complex pathways hamper optimization, especially at lower temperatures. Further research is needed to enhance catalyst performance, broaden the substrate scope, and improve industrial scalability.

Scheme 8

In 2024, Phungpis et al.[45] reported an intermolecular Stetter reaction between aromatic aldehydes 23 and α,β-unsaturated compounds 24 catalyzed by N,N-dimethylbenzimidazolium iodide catalyst C' 7 under microwave irradiation (MW) (Scheme 9). In the absence of an organic solvent, the reaction produced the desired products 25a – l in excellent yields (85 – 96%). These results were compared with the yields of 1,4-addition products 25 produced by the previously reported[42] intermolecular Stetter reaction catalyzed by N,N-dimethyl­benzimidazolium iodide catalyst C' 7 in a green solvent (water) or, alternatively, by the catalyst C' 7 under microwave irradiation. Reactions carried out in water without microwave assistance gave lower yields (58 – 77%) and were significantly more time-consuming, while those microwave-assisted carried out in a solvent-free fashion provided higher yields (85 – 96%). The hydration of hydroxide anions, which possibly prevents the production of carbenes, resulted in the reduced yields in water-assisted reactions. By breaking these hydrogen bonds, microwave irradiation increased the process efficiency by producing free hydroxyl ions and water molecules. Furthermore, the microwave assistance has been shown to be more efficient in producing 1,4-addition products as it could speed up the reaction up to 200 times compared with the thermally driven reaction. Catalyst C' 7 can be recycled up to four times in the solvent-free, microwave-assisted intermolecular Stetter reaction with just a little decrease in the product yield. This study contributes to the development of green chemistry by utilizing solvent-free methods and recyclable catalysts, minimizing waste and environmental impact. Furthermore, it expands synthetic possibilities, facilitates future research, and provides economic benefits through the cost-effective catalyst reuse.[45]

Scheme 9

2.2. Enzyme-catalyzed Stetter reaction

In 2021, Chen et al.[46] reported the first stereoselective intramolecular Stetter reaction of (E)-4-(2-formylphenoxy)but-2-enoate 29 catalyzed by benzaldehyde lyase from Pseudomonas fluorescens (pf BAL) to afford 1,4-dicarbonyl products 30a – j (Scheme 10). Screening of different enzymes using molecular dynamics (MD) simulations was performed to determine which thiamine diphosphate (ThDP)-dependent enzymes would be compatible with the model substrate, (E)-4-(2-formylphenoxy)but-2-enoate 29, and pf BAL was found to be an effective enzyme due to its large active-site pocket compatible with the substrate. The intramolecular stereoselective Stetter reaction with a wide range of substrates 29 catalyzed by ThDP-dependent pf BAL enzyme in the presence of 20 mol.% methyl tert-butyl ether (MTBE) was investigated. It was found that substrates with electron-rich, electron-deficient, and electron-neutral substituents all successfully gave the desired products 30a – j in high yields (60 – 99%) and with high stereoselectivity values (enantiomeric ratio (er) from 89 : 11 to 99 : 1). Its operational simplicity, mild reaction conditions, high yields and good stereoselectivity make it even more applicable than traditional chemical synthesis, offering a more sustainable and environmentally friendly way to produce important chiral products.

Scheme 10

In 2024, MacAulay et al.[47] functionalized a protein scaffold with a thiamine-inspired NHC to create an artificial enzyme, Stetterase (ArtiSt), which enabled a stereoselective intramolecular Stetter reaction under mild conditions with low catalyst loading. The steroid carrier protein (SCP) functionalized with maleimide N-benzyl thiazolium salt (MBnThz) C13 was synthesized by modifying human steroid carrier protein (hSCP A100C) 31 with a thiazole-based NHC C'13, which was then tested as a catalyst. Substrate 32 was converted into Stetter product 33 using 2 – 4 mol.% ArtiSt (MBnThz-functionalized SCP) C13, 50 mM 4-(2-hydroxyethyl)-1-piperazineethane­sulfonic acid (HEPES) to maintain pH, at 30°C for 18 h under reflux conditions (Scheme 11). The study emphasized the importance of selecting the appropriate protein scaffold for optimizing catalytic activity. Targeted mutation (A100C) enabled successful functionalization, enhancing Stetter reaction catalysis. Thermus thermophilus SCP (TTSCP) was identified as a promising scaffold and screening its different variants revealed that TTSCP L102C exhibited a 20-fold higher activity and highlighting its favorable structural and dynamic catalytic properties. In terms of stereoselectivity, the NHC-modified TTSCP L102C scaffold displayed low enantiomeric excess (ee) of 5% for the Stetter product, with a preference for the ­(R)-enantiomer as compared to the use of pf BAL, which provided 98% ee in the same reaction yielding predominantly the (S)-enantiomer. Nevertheless, ArtiSt is an interesting and quite promising catalyst; it still requires further improvement to achieve the high levels of efficiency and selectivity observed in natural catalytic systems.

Scheme 11

2.3. Photocatalytic (visible light-mediated) Stetter reaction

In 2020, Rai et al.[48] reported the synthesis of γ-ketonitriles through a novel photocatalytic intermolecular Stetter reaction. The Stetter reaction between acrylonitrile 34 and variously substituted aromatic aldehydes 23, 35, 36 or aliphatic aldehyde 37 was catalyzed by Cu@g-C3N4 photocatalyst (PC) in water at room temperature under visible light irradiation to produce γ-ketonitriles 38a – l, 39 – 41 in 80 – 95% yields (Scheme 12). No particular effect of the phenyl ring substituents was observed and even under the same conditions, aliphatic cyclic aldehyde 37 was converted into corresponding product 41 in 80% yield.

Scheme 12

According to the proposed mechanism, the process starts when visible light converts PC (Cu@g-C3N4) into an excited state PC*, which abstracts hydrogen from aldehyde 23 via homolytic cleavage of the C – H bond to generate acyl radical Int 15 and PCH* (Scheme 13). Acyl radical Int 15 adds to α,β-unsaturated nitrile 34 to form the adduct radical Int 16, and the catalytic cycle is closed with the hydrogen transfer from PCH* to radical Int 16 to afford the desired γ-ketonitrile product 38a – l. The authors highlighted the versatility and the operational simplicity of the developed procedure, the wide substrate scope, and the possibility of reusing the catalyst in multiple catalytic cycles. All this indicate its potential as a sustainable alternative for the synthesis of γ-ketonitriles.

Scheme 13

Metal-catalyzed reactions are a very important tool in organic synthesis because they enable the efficient formation of complex bonds under mild conditions.[49] In 2024, Pilkington et al.[50] reported a novel synthetic strategy based on transition metal-catalyzed C – H functionalization of benzoylsilanes 42 followed by a photochemical Stetter-type reaction to construct benzocyclobutenone derivatives. First, olefinated acylsilanes 44 were produced by acylsilane-directed Ru(II)-catalyzed C – H olefination of benzoylsilanes 42 with vinyl ketones 43 in high yields and with high selectivity (Scheme 14). After that, acylsilane 44 undergoes visible-light-induced intramolecular Stetter-type reaction via the reactive siloxycarbene intermediate Int 17 to give silyl enol ether 45'. Subsequent hydrolysis of the latter affords benzocyclobutenone derivatives 45a – x. This tandem reaction exploits the dual role of acylsilanes: as directing groups for C – H activation and as precursors for photochemically generated siloxycarbenes. A wide range of substrates was tested in this reaction, including various vinyl ketones and electron-rich and electron-deficient benzoylsilanes, and emphasized the function of trifluoroethanol (TFE) as a solvent to improve reaction yields. The proposed reaction mechanism involving the reversible 1,4-addition of the siloxycarbene to the tethered vinyl ketone and the irreversible silyl transfer was supported by DFT (Density functional theory) calculations. This method may find application in the synthesis of complex natural compounds and medicinal drugs. It should however, be noted that the photocyclization was relatively slow (12 – 24 h), and asymmetric applications remain unexplored. Nevertheless, this work represented a creative fusion of C – H activation and photochemical umpolung reaction, opening new avenues for carbene-mediated conjugate additions.

Scheme 14

2.4. Stetter reaction using miscellaneous reaction conditions

The enantioselectivity in the intermolecular Stetter reaction has long been challenging for researchers, who utilized different NHC catalysts to achieve 1,4-dicarbonyl compounds in good yields. Bis(amino)cyclopropenylidenes carbenes (BACs) were proven to be very stable and effective catalysts for the intermolecular Stetter reaction,[51] and their outstanding performance gave rise to the synthesis of novel chiral backbones with high enantioselectivity. In 2021, Khalkhali et al.[52] synthesized unique chiral BAC catalysts C'14 – C'18 and described the first highly enantioselective intermolecular Stetter reaction between aldehydes and enones. Chiral pre-catalyst C'14 showed low enantioselectivity due to the C – N bond rotation. To restrict the rotation and improve enantioselectivity, C2-symmetric bulky amino substituents were used, which proved to be more effective than the use of fused rings. In comparison, piperidine-derived BAC catalyst C'15 enhanced enantioselectivity at the expense of reactivity, while pyrrolidine-derived BAC catalysts C'16 – C'18 combined high selectivity with 92% conversion. Excellent yield of compound 48l (95%) and high enantioselectivity of compound 48f (92%) were achieved in the Stetter reaction between aromatic aldehyde 46 and enones 47 catalyzed by 10 mol.% chiral BAC catalyst C'17 (Scheme 15). Interestingly, unexpectedly high enantio­selectivities required a substoichiometric amount (20 mol.%) of water. The authors suggest that water molecules might form hydrogen bond networks stabilizing transition states, and also facilitate catalyst recovery in the Stetter reaction. The origin of enantioselectivity and the special role of water in the BAC-catalyzed Stetter reaction were investigated computationally. The BAC-catalyzed Stetter reaction tolerates a broad range of substrates, including differently substituted aldehydes and enones. Moreover, BACs have demonstrated the ability to catalyze 1,6-conjugate addition reactions, which expands the practical applicability, highlights their versatility and potential for wider applications of the above methodology in synthetic organic chemistry.

Scheme 15
Structures C'14 – C'18

In 2020, Phungpis and Hahnvajanawong[43] reported the 1-butyl-3-methylimidazolium bromide ([Bmim]Br)-mediated Stetter reaction between aromatic aldehydes 23 and acrylonitrile or ethyl acrylate 24 in the presence of NaOH, where ([Bmim]Br) C'19 acted both as a solvent and precatalyst generating the corresponding NHC in situ (Scheme 16). The reaction produced 1,4-addition products 25a – h in good yields along with aroin derivatives 26a – d as side products. Acrylonitrile was more reactive than ethyl acrylate in the Stetter reaction. Thus, [Bmim]Br proved to be a suitable catalyst for the Stetter reaction, enabling the production of key 1,4-dicarbonyl compounds, although with satisfactory selectivity.

Scheme 16

In 2020, Nicholson et al.[53] were the first to develop a mechanochemical modification of NHC-catalyzed inter­molecular and intramolecular Stetter reactions. Various bases, grinding auxiliaries, precatalysts, and grinding speeds were screened to achieve optimal conditions for the acyl anion activation mode in intramolecular and intermolecular Stetter reactions. Intramolecular Stetter reaction catalyzed by 5 mol.% pre-NHC catalyst C' 20 under ball-milling conditions produced chromanone derivatives 50a – c and 3-oxo-2,3-dihydro­benzofuran derivatives 52a – c from compounds 49 and 51, respectively, in good yields (Scheme 17). However, the pre-NHC catalyst C' 20 did not show satisfactory results in the intermolecular Stetter reaction. In this case, thiazolium catalyst C' 21 performed best in the intermolecular Stetter reaction between aromatic aldehydes 53 and chalcone 54 under ball-milling conditions to afford 1,4-diketones 55a – i in moderate to good yields (Scheme 18). It was also found that an intramolecular Stetter reaction catalyzed by triazolium pre-NHC C' 22 under ball-milling conditions can proceed enantioselectively with up to 92% ee and in 96% yield (Scheme 19). NHC-catalyzed acyl anion mechanochemistry under ball-milling conditions offers a novel solvent-free approach in organocatalysis. It enables diverse Stetter reactions with potential for high yields and enantioselectivity. However, challenges in optimizing yields, reproducibility, and reaction conditions highlight the need for further research to maximize the methodology’s potential in practical applications.

Scheme 17
Scheme 18
Scheme 19

In 2022, Cai et al.[54] reported a novel intermolecular Stetter reaction between aromatic aldehydes 56 and electron-deficient 2-bromo-3,3,3-trifluoropropene (BTP) 57, catalyzed by the in situ generated α-trifluoromethyl carbanion Int 19. The reaction produces various β-alkoxyl-β-trifluoromethylated ketones 59 in moderate to high yields (Scheme 20). A variety of aliphatic/aromatic/heteroaromatic aldehydes and different alcohols were well tolerated and provided the desired products, except for an aliphatic aldehyde, which did not produce any product. The desired products were undetectable when ester, phosphate ester, sulfonyl, phenyl, and amide were used instead of α-trifluoromethyl group.

Scheme 20

The proposed mechanism includes first the formation of an alkoxy anion Int 18 from alcohol 58, then the alkoxy anion Int 18 and BTP 57 react to form the α-trifluoromethyl carbanion catalyst Int 19 (Scheme 21). The latter reacts with aldehyde 56 to produce an O-anion intermediate Int 20, which converts to the carbanion intermediate Int 21 via a 1,2-proton transfer. Then, intermediate Int 21 adds to BTP 57 to generate an unstable α-trifluoromethyl carbanion Int 22, which undergoes a 1,4-proton transfer to produce an ­O-anion intermediate Int 23. Intermediate Int 23 releases α-trifluoromethyl bromide Int 24 and regenerates the α-trifluoro­methyl carbanion catalyst Int 19. Subsequent nucleophilic substitution of α-trifluoromethyl bromide Int 24 by the alkoxy anion yields the final product 59. This study introduced a novel umpolung strategy using an α-trifluoromethyl carbanion catalyst, enabling efficient C – C bond formation and high-yield synthesis of functionalized ketones, the further modification of which give rise to bioactive compounds, e.g., potent anticancer agent I 60 and ERK (extracellular signal-regulated kinase) inhibitor II 61. In addition, the trifluoromethyl group enhances the lipophilicity and stability of the resulting compounds, making them valuable for pharmaceutical and agrochemical applications. However, challenges such as intermediate stability, reaction specificity, complex mechanism, scalability, and limited substrates require further research and optimization.

Scheme 21
Structures 60, 61

Since the discovery of the intermolecular Stetter reaction, it has been restricted only to the use of the aromatic aldehydes to produce 1,4-addition products along with acyloin by-products and till 2021, direct synthesis of aliphatic 1,4-diketones remained a synthetic challenge. In 2021, Brimble et al.[55] reported a new N-mesityl thiazolium NHC catalyst C' 29, which demonstrated high performance in the intermolecular Stetter reaction of sterically non-trivial aliphatic aldehydes 1a – i with enones 66, 67 to generate 1,4-diketones 68a – i and 69, respectively (Scheme 22).[55] Both previously described C'1, C' 8, C' 21, C'23 – C'25 and novel catalysts C'26 – C'29 were tested in the intermolecular Stetter reaction of aliphatic aldehydes, and among these, the newly synthesized N-mesityl-substituted thiazolium catalyst C' 29 showed remarkable catalytic activity and good yield in just 30 minutes. For these substrates, catalyst C' 29 outperformed the conventional catalyst C'1 in terms of both yields and reaction time, but its efficiency decreased in the case of aromatic aldehydes suggesting that its scope was only restricted to aliphatic systems. Percentage buried volume (%VBur) and σ-donating capacity were used as a quantification of the catalyst’s steric and electronic properties, which affect its performance. The proposed method for percentage buried volume (%VBur) calculation provides useful parameter for the synthesis and screening of NHC catalysts thereby broadening their application in the synthesis of complex organic molecules under mild conditions.

Scheme 22
Structures C'1, C'8, C'21, C'23 – C'25

α-Ketoglutarate (α-KG) is the substrate for the mutant isocitrate dehydrogenase 1 (IDH1) enzyme; unusual α-KG metabolism is associated with tumour cell differentiation and malignant development. IDH1 mutations cause the reduction of α-KG to 2-hydroxyglutarate (2-HG), which inhibits α-KG-dependent dioxygenases and have a number of other effects. Accurately detecting 2-HG in tumours using nuclear magnetic resonance (NMR), the challenge due to spectral overlap between naturally abundant [5-¹³C]-α-KG and [1-¹³C]-2-HG signals. The resulting [1-13C-5-12C]-α-KG eliminates signal overlap from naturally occurring [5-13C]-α-KG. In 2021, Miura et al.[56] reported a new one-pot oxidative Stetter reaction between 2-bromo-1-morpholinoethan-1-one-1-13C 72 and benzyl acrylate-1-12C 75 catalyzed by thiazolium salt C'30 and ­N-hydroxy-4-N,N-dimethylaminopyridine for in situ oxidation to form [1-13C-5-12C] α-ketoglutarate (α-KG) 78 (Scheme 23). The starting material 72 was synthesized from N-hydroxy­succinimide 70 and 1-13C-labeled 2-bromoacetic acid 71, activated with N,N'-diisopropylcarbodiimide (DIC) followed by substitution with morpholine. Benzyl acrylate-1-12C 75 was obtained via the Grignard reaction of vinylmagnesium bromide 73 with 12C – CO2 74, followed by esterification to afford the product 75 in 44% yield over two steps. Under optimized conditions, the one-pot oxidative Stetter reaction furnished compound 76 in 90% yield. Subsequently, the resulting compound 76 underwent a series of transformations to achieve the α-KG 78 in 95% yield. The novel [1-13C – 5-12C]-α-ketoglutarate probe eliminates spectral overlap at C-5, enabling unambiguous detection of [1-13C]-2-hydroxyglutarate in IDH1 mutant assays and HCT116 IDH1 R132H cells. This probe enhances diagnostic accuracy and offers a versatile tool for probing α-KG metabolism across diverse biomedical applications. However, its introduction into clinical practice requires additional research.

Scheme 23

3. Natural products syntheses

Synthesis of natural products involves constructing complex molecules found in nature using controlled chemical reactions.[57] Such studies facilitate a deeper understanding of molecular structures, functional behaviour, and their prospective applications in medicinal chemistry and biologically active compounds.[58-60]

3.1. Alkaloids

In 1999, Higa and co-workers[61] isolated iheyamines A and B containing azepino-2,2'-bisindole moieties from a colonial ascidian, Polycitorilla sp. from Iheya Island, Okinawa. Their limited bioavailability and cytotoxicity against cancer cells have sparked interest in their total synthesis. Till 2020, only three iheyamine A syntheses have been reported because producing the unsymmetrical 2,2'-bisindole scaffold with different substituents on each indole ring was the main difficulty in synthesizing iheyamines. Cross-coupling between two indole scaffolds or cyclization of uncyclized precursors to produce an unsymmetrical 2,2'-bisindole framework are two approaches that can address this issue. Iheyamine A was previously synthesized via cross-coupling between two indole scaffolds; however, this cyclization method did not allow the synthesis to be completed.[62-65] In 2020, Jeon et al.[66] described the second approach to the total synthesis of iheyamine A 83, which involved first the reaction of ethyl 2-aminocinnamate 79 with N-benzyl-5-methoxyindole-2-carboxaldehyde 80 to give aldimine Int 25, which was not isolated (Scheme 24). Aldimine Int 25 underwent the cyano-catalyzed imino-Stetter reaction to afford the unsymmetrical 2,2'-bisindole-3-acetate 81 in 91% yield. Next, compound 81 was converted into lactam 82 through nitrosylation (75% yield), reduction, and cyclization using NaOBut in 67% yield over two steps. In the next step, lactam 82 was reduced with BH3 to afford N-benzyl tetrahydroiheyamine A Int 26, followed by debenzylation with AlCl3 and subsequent aerobic oxidation to furnish finally iheyamine A 83 in 56% yield. This synthesis efficiently constructed the complex azepino-2,2'-bisindole core, with the imino-Stetter reaction being the key step.

Scheme 24

Antirhine, belonging to the Antirhine family of indole monoterpene alkaloids, possesses a tetracyclic indolo­quinolizidine structure with a distinctive C-18 – C-19 vinyl/ethyl attachment on C-20 and a thermodynamically susceptible anti-relationship between C-3 and C-15 stereocentres.[67-69] Traditional synthesis of antirhine compounds was based on unique starting materials with predetermined stereochemistry at C-15 and C-20, resulting in specialized and non-generalizable methods. These procedures were often time-consuming and made it difficult to control stereochemical interactions, especially the trans configurations of C-3 and C-15.[70-75] A more efficient and adaptable synthesis using a common intermediate was required to overcome these issues. In 2020, Bae et al.[76] reported a novel total synthesis of (±)-20-epi-antirhine 88, (±)-20-epi-18,19-dihydroantirhine 89, (±)-antirhine 91, and (±)-18,19-dihydroantirhine 92 through the cyanide-catalyzed imino-Stetter reaction (Scheme 25). The reaction between ethyl 2-amino­cinnamate 79 and 4-bromopyridine-2-carboxaldehyde 84 gave compound Int 27, which was further subjected to the intramolecular imino-Stetter reaction catalyzed by NaCN in DMF in the presence of molecular sieves (MS) 4 Å to afford compound 85 in 92% yield. After a series of reactions, compound 85 was converted into the key indoloquinolizidine 86, which was diverted into two different synthetic strategies. According to the first strategy, compound 86 was reacted with lithium hexamethyldisilazide (LiHMDS) followed by vinyl sulfoxide to give compound 87, and after several steps, 87 was converted into 20-epi-antirhine 88, which was further reduced to 20-epi-18,19-dihydroantirhine 89 in 98% yield. Compound 90 was obtained by the second strategy via the reaction of compound 86 with LiHMDS and then with methoxymethyl chloride (MOMCl). After a series of steps, 90 was transformed into antirhine 91, which was further reduced to 18,19-dihydroantirhine 92 in 97% yield. The cyanide-catalyzed imino-Stetter reaction, which produced derivatives of indole-3-acetic acid with a pyridine ring at position 2, was the key step providing 92% yield.

Scheme 25

In 2021, Park et al.[77] reported a new synthetic approach to antirhine alkaloids through the cyanide-catalyzed Stetter reaction and the trans-selective installation of homoallylic alcohol side chain at the C-15 position. Various strategies for the synthesis of antirhine and its 20-epimers have been used, but satisfactory results have not been achieved. The synthesis began with the reaction of ethyl 2-aminocinnamate 79 with 4-bromopyridine-2-carboxaldehyde 84 to form the aldimine Int 27 (Scheme 26). The intermediate Int 27 underwent an intramolecular CN-catalyzed Stetter reaction to afford compound 85. After that, compound 85 followed a series of reactions and formed a trans-indoloquinolizidine 86, which was reacted with LiHMDS and 2-(trimethylsilyl)ethoxymethyl (SEM) chloride to give compound 93. Intermediate 93 followed a series of reactions, via reduction of the ester with L-selectride, Dess-Martin oxidation, Wittig reaction, and deprotection to produce the desired product antirhine 91 in 47% yield over 3 steps. Antirhine 91 was reduced to 18,19-dihydroantirhine 92 in 97% yield. 20-Epi-antirhine 88 and 20-epi-18,19-dihydro­antirhine 89 were synthesized according to the previously reported method.[76]

Scheme 26

Hinckdentine A, containing a tri-brominated indolo[1,2-c]-quinazoline skeleton with a seven-membered lactam ring, was isolated from the marine bryozoan Hincksinoflustra denticulata in 1987.[78] Despite its extremely low isolated yield (0.0005%) and unexplored biological activity, its complex structure became a significant point of interest for synthetic chemists. Till 2021, there were three known total syntheses of Hinckdentine A, including two asymmetric approaches and one 8-desbromo­hinckdentine A total synthesis. In previous approaches, bromination was performed in the final step, but this led to inseparable mixtures of brominated compounds and required extra steps to control reactivity.[79-82] In 2021, Jeon et al.[83] reported a novel total synthesis using a starting material initially containing bromine atoms at the appropriate positions.[83] The reaction of ethyl 2-amino-3,5-dibromocinnamate 94 with 5-bromo-2-nitrobenzaldehyde 95 in the presence of TiCl4, Et3N, in DCM gave aldimine 96 (Scheme 27). This aldimine 96 was then subjected to the intramolecular CN-catalyzed imino-Stetter reaction, which led to 2-aryl-substituted indole-3-acetic acid ester 97 in 87% yield. Then, a series of steps via the formation of six membered-ring-containing compound 98 and seven-membered ring-containing compound 99 delivered Hinckdentine A 100. The incorporation of bromine atoms during the synthesis of starting materials and the construction of the seven-membered ring via aldol condensation distinguishes this approach from previous methods. An asymmetric version of this total synthesis is currently under development.

Scheme 27

Numerous plants and animals contain β-carboline alkaloids, which have anti-inflammatory, anti-malarial, and anti-cancer effects. Many bis-β-carboline alkaloids from the Simaroubaceae family have already been identified.[84][85] Picrasidine R contains a 1,4-diketone linker between two β-carboline components, while picrasidines G, S, and T have an indolotetrahydro­quinolizinium (ITHQ) skeleton.[86-88] At room temperature, these alkaloids easily racemize in chloroform despite having a stereogenic core and often show cytotoxic activity.[89][90] In 2023, Wang et al.[91] reported the total synthesis of several bis-β-carboline alkaloids (Picrasidines I, G, R, S, and T), where picrasidine R was synthesized through a thiazolium-catalyzed Stetter reaction. The total synthesis commenced with the condensation of tryptamine hydrochloride 101 and 2,2-dimethoxy acetaldehyde 102 under acidic conditions to create the tetrahydro-β-carboline skeleton of the compound, which was then N-tosyl-protected to give compound 103 (Scheme 28). After that, compound 103 underwent a multi-step intramolecular reaction to form the fused bicyclic structure 104. Vinylation of compound 104 through the Grignard reaction followed by the Dess-Martin oxidation afforded compound 105. Then, compounds 105 and 104 underwent a thiazolium C'21-catalyzed intermolecular Stetter reaction in the presence of Et3N to give picrasidine R 106 in 93% yield.

Scheme 28

Stemona alkaloids, traditionally recognized for their antitussive and insecticidal properties, exhibit notable structural and pharmacological diversity, primarily originating from Stemonaceae species.[92] While most members of this class contain saturated nitrogen-based heterocycles, a subset features oxidized pyrrole cores and a distinctive oxaspirocyclic butenolide motif. Previous total syntheses have elegantly accessed Stemona alkaloids via 12 – 22 step sequences. A central synthetic challenge across these efforts lies in the construction of the densely functionalized spirobutenolide-tetrahydrofuran ring system, which has consistently required nine or more steps to assemble.[93-96] In 2025, Akkawi and Nicewicz[97] reported innovative and efficient photochemically enabled total synthesis of three members of the Stemona alkaloid family (bis­dehydrostemoninine, bisdehydrostemoninine A, bisdehydroneo­stemoninine), highlighting the power of photocatalysis to streamline complex natural product synthesis. The synthesis of bisdehydrostemoninine A 112 involved a Stetter-type reaction catalyzed by the hydrogen atom transfer (HAT) photocatalyst tetrabutylammonium decatungstate (TBADT), facilitated with a chiral Brønsted acid (CBA). The synthesis was initiated by the photoredox hydroarylation reaction between alkyne 107 and 2-bromo-pyridine 108, yielding a mixture of (1 : 1 E/Z) alkene isomers 109 (Scheme 29). This mixture then underwent a series of steps to form the compound 110. The synthesis of bisdehydrostemoninine A 112 was initially considered as a Stetter reaction, but formyl pyrroles proved incompatible with typical NHC catalysts. To overcome this, TBADT-mediated photochemical C – H functionalization with Giese acceptors was followed, which required a diastereocontrolled chiral catalyst. So, the photochemically-assisted Stetter-type reaction of compounds 110 and 111 catalyzed by 10 mol.% TBADT using 10 mol.% CBA resulted in the sterocontrolled formation of bisdehydrostemoninine A 112.

Scheme 29

3.2. Sesquiterpenes

Methods for the isolation and purification of the spiro[4.5]­decanecarbon core-containing acorane-alaskan sesquiterpenes, schisansphenin B from Schisandra sphenanthera (2011) and 15-hydroxyacora-4(14),8-diene from Juniperus chinensis (1996) were reported. Schisansphenin B demonstrates significant immune modulatory activity, but no biological effects have been reported for 15-hydroxyacora-4(14),8-diene. Despite sharing an identical carbon skeleton, the two compounds differ in the stereochemical orientation of the double bond within the six-membered ring and the positioning of the isopropyl group; however, their absolute configurations have yet to be definitively established.[98-100] The primary challenge in synthesizing acorane-type natural products lies in the precise asymmetric installation of the anticipated stereostructures on the spiro quaternary carbon atom and the adjacent chiral centres. A comprehensive literature review indicates that various synthetic strategies have been explored to construct the acorane skeleton effectively.[101-105] In 2022, Hsu et al.[106] reported a new synthetic approach for the total synthesis of (+)-5-epi-schisansphenin B 119 and proposed the structure of (+)-15-hydroxyacora-4(14),8-diene 120 (Scheme 30). The synthesis started from malonic acid 113, which was converted into (E)-5-methylhex-3-en-1-ol 114 over two steps. After that, compound 114 was reacted with triflate 115 to give enantioselective enone-aldehyde 116 through the palladium-catalyzed redox-relay Heck alkenylation. Then, enone-aldehyde 116 underwent an intramolecular Stetter reaction catalyzed by the triazolium salt C'31 to yield spirocyclic 1,4-dione 117. After a series of reactions, compound 117 was converted into compound 118, which was hydrolyzed to (+)-5-epi-schisansphenin B 119. On the other hand, (+)-15-hydroxyacora-4(14),8-diene) 120 was produced by using DIBAL-H to reduce the compound 118 ester group to alcohol. The formation of spirocyclic 1,4-dione was the crucial step in the synthesis. This was achieved by three types of reactions, but the intramolecular Stetter reaction proved to be the most successful.

Scheme 30

3.3. Miscellaneous

Perylenequinone-derived natural products are divided into two main classes: fully conjugated perylenequinones like calphostins and hypocrellins, and those partially reduced (di-, tetra-, or hexahydroperylenequinones) such as altertoxins.[107-113] The latter are fungal metabolites with toxic relevance, often lacking additional carbon substituents and featuring methylated hydroxy groups and till 2024, no total synthesis has been achieved for these compounds despite efforts. Altertoxins are important metabolites of fungi that are divided into two subtypes, the biphenyl-type (altertoxin I, II, stempyltoxin I) and the dihydroanthracene-type (e.g., altertoxin III), which feature two stacked benzene rings and two diagonally oriented benzene rings, respectively.[113][114] In 2024, Gutsche et al.[115] described the syntheses of altertoxin I framework by following different synthetic routes; one route involved the formation of the phenanthrenequinone through the intramolecular Stetter reaction. In the first step, the starting material, bromobenzaldehyde 121, was converted into the biphenyl dialdehyde compound 124 by the direct Ulmann reaction (Scheme 31). In an alternate approach, bromo­benzaldehyde 121 was protected by an acetal formation (compound 122), which was boronated to give the intermediate 123, followed by the Suzuki coupling and transformation to biphenyl dialdehyde 124. The latter compound 124 underwent an intramolecular Stetter reaction catalyzed by thiazolium salt C'21 in the presence of triethyl amine and methanol to form cyclized acyloin, which was immediately converted into phenanthrenequinone 125 through oxidation. Compound 125 was reacted with MeMgI to form the trans diastereoisomer of pinacol 126 which was converted into Altertoxin I framework 127 after a series of steps. In another approach, compound 125 was reacted with 3-benzyloxypropyl magnesium bromide to form compound 128 which was also expected to afford Altertoxin I 127, but the authors did not completed this synthetic route.

Scheme 31

In 1998, Boyd and co-workers[116] isolated two novel oligostilbenes, malibatols A and B, from Hopea malibato leaves, which showed significant cytotoxic activity against CEM-SS cells in antiviral assays. Shoreaphenol (or hopeafuran), an oxidized structural derivative of malibatol A, was subsequently isolated from Shorea robusta and Hopea utilis.[117][118] Despite their promising bioactivity and unique carbon frameworks, attempts to synthesize these oligostilbene natural products remain sporadic.[119-122] In 2024, Ranga et al.[123] reported a new approach to 9-phenanthrol derivatives from 2-(2-formylaryl)-aryl substituted p-quinonemethides (p-QMs) catalyzed by bis(aminoalkyl)cyclopropenylidene (BAC) through the intramolecular vinylogous Stetter reaction. In addition, this approach was effectively used to create the seven-membered (±)-shoreaphenol and (±)-malibatol A 134, natural products based on resveratrol. The synthesis of (±)-shoreaphenol and (±)-malibatol A 134 commenced with the reaction of 2-bromo-4,6-dimethoxybenzaldehyde 129 and 2,6-di-tert-butylphenol 130 to give 2-bromoaryl-substituted p-QM 131, which was converted into intermediate 132 via a series of reactions (Scheme 32). The resulting intermediate 132 was then subjected to an intramolecular annulation (vinylogous Stetter reaction) catalyzed by 10 mol.% BAC C'32 and 20 mol.% DBU to produce seven-membered carbocycle 133. After that, intermediate 133 was subjected to AlCl3 in benzene to remove the protecting t-butyl group and form key structure 134. This methylated shoreaphenol derivative 134 may be used to synthesize (±)-shoreaphenol and (±)-malibatol A natural product.

Scheme 32

Furancarboxylic acids, in particular penicilfuranone A, represent a class of bioactive aromatic polyketides with complex tricyclic frameworks and multiple stereocentres, including challenging quaternary centres. Isolated from Penicillium sp. sh18, penicilfuranone A exhibits potent antifibrotic activity and poses significant synthetic challenges due to its highly oxidized benzocyclohexanone core and acid-sensitive tertiary alcohol moiety.[124] Its biosynthesis was proposed to proceed via gregatin A and phenol intermediates, involving a sequence of Michael and aldol additions followed by benzylic oxidation. A key transformation includes a vinylogous internal substitution (SNi) reaction that forms a quaternary stereocentre through an enantioselective internal substitution.[125] In 2025, Ding et al.[126] reported the NHC-catalyzed asymmetric synthesis of penicilfuranone A 143 through a Stetter-aldol cascade reaction. The synthesis commenced with the preparation of an aromatic aldehyde 137 derived from diphenol 135 (Scheme 33). The OH group of compounds 135 was first protected with an allyl group using allyl bromide and potassium carbonate, and then the aldehyde group was reduced to a primary alcohol moiety with sodium borohydride to give compound 136. Next, treatment with BuLi generated an aryllithium species, which reacted with acetaldehyde to install a secondary alcohol at the benzylic position, producing compound 137 in 72% yield. At the same time, an aliphatic unsaturated ketone 138 underwent an asymmetric cyanosilylation catalyzed by (S,S)-Al-salen, yielding a chiral cyanohydrin 139, which was further converted to gregatin A 140. Compounds 137 and 140 were then subjected to a key NHC-catalyzed Stetter–aldol cascade reaction in the presence of cesium carbonate and DCM. Herein, the NHC-catalyzed umpolung strategy was followed, where a carbene catalyst activated benzaldehyde to generate a nucleophilic Breslow intermediate. This intermediate underwent a formal [4 + 2] annulation with an electron-deficient alkene (gregatin A), facilitating the formation of the skeleton with high stereoselectivity via a Stetter – Aldol cascade reaction. This step rapidly constructed the highly oxygenated and stereochemically dense benzocyclohexanone ring system that mimics the B-ring of penicilfuranone A. Due to the complexity of the system, several diastereomers 141a, 141b, 141c and 142 were formed, prompting selective epimerization at C-15, and in some cases, sequential epimerization at C-14, C-15, and C-19 to achieve the desired stereochemical configuration 142. The final step involved selective deallylation and subsequent transformations to install the stereocentres, culminating in the asymmetric total synthesis of penicilfuranone A 143, with the Stetter reaction playing a crucial role in forming the core framework through the umpolung approach. In addition to simplifying the synthesis of penicilfuranone A 143, this novel synthetic method provides possibilities for the production of other 4-hydroxytetralone-containing natural products.

Scheme 33

4. Syntheses of drugs

Poly(ADP-ribose) polymerase inhibitor (PARP) rucaparib is approved for ovarian and prostate cancer treatment and is undergoing clinical trials for other cancers.[127-129] Its structure features a highly substituted indole core fused with a seven-membered lactam ring. Due to the challenge of obtaining indole derivatives with precise substitutions, previous syntheses were based on constructing the indole core from meta-fluorobenzoic acid derivatives.[130-132] In 2022, Park and Cheon[133] reported a concise total synthesis of rucaparib by the Heck reaction of commercially available reactants, aryl iodide 144 and acrylonitrile 34, which gave (E)-2-aminocinnamonitrile 152 (Scheme 34). Next, compound 152 was reacted with aldehyde 153 to give an aldimine, which further underwent the intramolecular CN-catalyzed imino-Stetter reaction to afford indole-3-acetonitrile 154 in 80% yield. After a series of steps, rucaparib 157 was obtained. This synthetic route has the advantage of using commercially available starting materials and achieving the total synthesis of rucaparib in only three separation steps with an overall yield of 54%. The same year, the authors[134] reported another two approaches for the concise synthesis of rucaparib from commercially available starting materials based on the cyanide-catalyzed imino-Stetter reaction as a key step. The synthesis commenced with the reaction of the commercially available starting material, meta-fluorobenzoate 145, with N-bromosuccinimide (NBS), followed by the addition of triphenylphosphine to produce the intermediate phosphonium salt 146 in 90% yield over two steps (see Scheme 34). After that, two different approaches were followed. According to the first approach, the intermediate 146 underwent the Wittig reaction with ethyl glyoxalate 147 to give cinnamate, which was then converted into 2-aminocinnamate 152 by the reduction of the nitro group. In the second approach, phosphonium salt 146 reacted with glyoxalamide 148 and Boc2O to form the ­(Z)-cinnamamide intermediate 149, which was converted into compound 150 and after several steps, compound 150 delivered (E)-cinnamamide intermediate 152. Then, intermediate 152 reacted with aldehyde 153 to form an aldimine, which was then converted into substituted indole intermediate 154 (80%) through an intramolecular CN-catalyzed Stetter reaction. Finally, via several steps, compound 154 gave rise to rucaparib 157. The modified synthetic approach to rucaparib involving the key Heck reaction and Stetter reaction reported in the previous study[133] was also mentioned. In the follow-up study,[135] a scalable method was described for synthesizing rucaparib using commercially available starting materials, methyl 5-fluoro-2-methyl-3-nitrobenzoate 145 and 4-cyanobenzaldehyde 155 (see Scheme 34). Compound 145 reacted with N,N-dimethyl­formamide dimethyl acetal (DMF · DMA) to form an enamine, which underwent the Strecker reaction with TMSCN to give an α-aminonitrile 151 (75% yield). Next, intermediate 151 was transformed into an E-isomer of 2-amino-cinnamonitrile 152 followed by oxidation with meta-chloroperoxybenzoic acid (mCPBA), K2CO3-induced Cope elimination, and reduction with Zn/AcOH. Then, compounds 152 and 155 fused in the presence of TiCl4 produced the corresponding aldimine, which subsequently underwent intramolecular CN˗catalyzed imino-Stetter reaction to give indole-3-acetonitrile 156 in 92% yield. After that, compound 156 was transformed into rucaparib 157 via several steps. The second-generation synthesis of rucaparib through the Heck reaction offers significant advantages, primarily due to its higher overall yield of 59%, a marked improvement over the 27% yield of the first-generation method based on the Heck reaction. This route also involves fewer separation steps, making it more practical and potentially more scalable for industrial production. In addition, the use of well-established reactions, such as the Heck coupling and the cyanide-catalyzed imino-Stetter reaction, enhances the reliability and reproducibility of the process.

Scheme 34

In 2024, Seo et al.[136] reported the radiosynthesis of [18F]rucaparib 157 based on a novel highly efficient synthesis of its precursor, pinacol boronate, from the commercially available starting materials. The first step was the Heck reaction between methyl 3-amino-5-chloro-2-iodobenzoate 158 and acrylonitrile 34, yielding the desired (E)-2-aminocinnamonitrile 159 (Scheme 35). Then, the reaction between 159 and aldehyde 153 in the presence of titanium (IV) chloride gave aldimine, which underwent the CN-catalyzed imino-Stetter reaction to yield indole-3-acetonitrile 160. Following the formation of the indole derivative 160, the nitrile group was chemoselectively reduced with cobalt boride to an amine, affording indoloazepinone while retaining the chlorine group. After that, the Suzuki – Miyaura borylation was performed involvig the halogen substituent at the C6-position of the indole to produce the pinacol boronate 161. The pinacol boronate was then used for the copper-mediated fluorination with 18F, resulting in the formation of [18F]rucaparib 157.

Scheme 35

Reactivation of p53 and induction of tumour cell apoptosis (RITA) is an anticancer agent featuring a 2,4-bonded thiophene-furan-thiophene scaffold with pendant hydroxymethylene moieties. It exerts cytotoxicity by disrupting the oncogenic p53 – HDM-2 interaction, leading to p53 activation and apoptosis. In addition, RITA downregulates oncogenic proteins such as Mcl-1 and c-Myc. Notably, its pro-apoptotic activity persists even in p53-deficient contexts, highlighting its broad therapeutic potential.[137-139] In 2024, Murugesh et al.[140] reported the synthesis of the RITA drug 166 through a concise and efficient sequence of reactions primarily utilizing a double Stetter reaction. First, the double Stetter reaction between thiophene-2-carboxaldehyde 162 and divinyl sulfone 163 occurred, catalyzed by benzyl thiazolium C'1 catalyst and sodium acetate in ethanol, to give 1,4-di(thiophen-2-yl)butane-1,4-dione 164 in 75% yield (Scheme 36). The intermediate 164 underwent the Paal-Knorr furan cyclization promoted by ­p-toluenesulfonic acid (PTSA) in boiling toluene to 2,5-di(thiophen-2-yl)furan 165, which was then subjected to the Vilsmeier – Haack di-formylation with phosphorus oxychloride in DMF to afford dialdehyde. The final reduction of the resulting dialdehyde using sodium borohydride efficiently produced the target molecule RITA 166 in 95% yield.

Scheme 36

5. Conclusion

To conclude, the Stetter reaction remains a cornerstone in modern organic synthesis, providing a reliable route to 1,4-dicarbonyl compounds via N-heterocyclic carbene catalysis. Its main advantage lies in enabling polarity inversion of carbonyl compounds, allowing efficient C – C bond formation under mild and selective conditions. In this review, recent methodological advancements, mechanistic insights, and the significance of the Stetter reaction in natural product and drug synthesis have been mentioned and explained. Recent innovations have addressed longstanding challenges such as enantioselectivity, substrate scope, and reaction efficiency through the development of chiral NHCs, photochemical protocols, and enzyme catalysis. Environmentally friendly approaches, including water-based and microwave-assisted reactions, demonstrate the potential for scalable and sustainable synthesis. Among its clear advantages are its high atom economy, operational simplicity, and adaptability to sustainable methods such as solvent-free, aqueous, or mechanochemical conditions. These developments have reduced environmental impact while maintaining high selectivity and yield. The introduction of chiral NHC catalysts has also made it possible to access enantioenriched products valuable in the synthesis of pharmaceutical and natural products. However, several challenges persist, such as limited reaction efficiency in the case of aliphatic aldehydes and achieving high enantioselectivity in intermolecular processes. Scale-up issues, catalyst recovery, and the stability of intermediates also restrict its industrial use. Therefore, further mechanistic studies and catalyst optimization are required. Looking forward, the Stetter reaction is expected to benefit from the integration of green technologies such as continuous-flow systems, electrochemical activation, and recyclable catalysts. The design of more tunable chiral NHCs and hybrid organoenzymatic catalysts could address current limitations and open new pathways for asymmetric synthesis. With ongoing innovation in methodology and sustainability, the Stetter reaction will continue to play a vital role in advancing both academic research and industrial chemistry.

Acknowledgement

Authors are thankful to the facilities provided by Government College University Faisalabad, Pakistan.

Conflict of interest

The authors declare no conflicts of interest.

6. List of abbreviations

Ac — acetyl,

ACHN — 1,1'-azobis(cyclohexanecarbonitrile),

All — allyl,

ArtiSt — artificial Stetterase,

BACs — bis(amino)cyclopropenylidenes carbenes,

[Bmim]Br — 1-butyl-3-methylimidazolium bromide,

Bn — benzyl,

Bpin — pinacol boronate ester,

B2pin2 — bis(pinacolato)diboron,

BTP — 2-bromo-3,3,3-trifluoropropene,

CBA — chiral Brønsted acid,

c-Myc — cellular myelocytomatosis,

DBU — 1,8-diazabicyclo [5.4.0]undec-7-ene,

DCE —1,2-dichloroethane,

DCM — dichloromethane,

DFT — density functional theory,

DIBAL-H — diisobutylaluminium hydride,

DIC — N,N'-diisopropylcarbodiimide,

Dipp — 2,6-diisopropylphenyl,

DMAP — 4-dimethylaminopyridine,

DMF —N,N-dimethyl formamide,

DMF · DMA — N,N-dimethylformamide dimethyl acetal,

DMSO — dimethylsulfoxide,

DMP — Dess-Martin periodinane,

EDCl —1-ethyl-3-(3-dimethylaminopropyl)carbodiimide,

ERK — extracellular signal-regulated kinase,

Fu — furyl,

HAT — hydrogen atom transfer,

HDM-2 — human double minute 2 protein,

HEPES — 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid,

2-HG — 2-hydroxyglutarate,

hSCP — human steroid carrier protein,

IC50 — half maximal inhibitory concentration,

IDH1 — isocitrate dehydrogenase 1,

ITHQ — indolotetrahydroquinolizinium,

α-KG — α-ketoglutarate,

LDA — lithium diisopropylamide,

LiHMDS — lithium bis(trimethylsilyl)amide,

MBnThz — maleimide N-benzyl thiazolium salt,

Mcl-1 — induced myeloid leukemia cell differentiation protein,

mCPBA — meta-chloroperoxybenzoic acid,

MD — molecular dynamics,

Mes — mesityl,

MOMCl — methoxymethyl chloride,

MS — molecular sieves,

MTBE — methyl tert-butyl ether,

MW — microwave irradiation,

Naph — naphthyl,

NBS — N-bromosuccinimide,

NHC — N-heterocyclic carbenes,

P53 — tumour protein p53,

PARP — poly(ADP-ribose) polymerase inhibitor,

PC — photocatalyst,

Pd2dba3 — tris(dibenzyllideneacetone)palladium,

pf BAL — Pseudomonas fluorescens benzaldehyde lyase,

PMB — p-methoxybenzyl,

p-QMs — p-quinonemethides,

PTSA — p-toluenesulfonic acid,

p-TsCl — p-toluenesulfonyl chloride,

Py — pyridyl,

RITA — reactivation of p53 and induction of tumour cell apoptosis,

SCP — steroid carrier protein,

SEM — 2-(trimethylsilyl)ethoxymethyl,

SNi — substitution nucleophilic internal,

Sphos — 2-dicyclohexy[phosphino-2',6'-dimethoxybiphenyl,

TFA — trifluoroacetic acid,

TBADT — tetrabutylammonium decatungstate,

TBDPS — tert-butyldiphenylsilyl,

TBS — tert-butyldimethylsilyl,

Tf — triflate (trifluoromethanesulfonyl),

TFE — trifluoroethanol,

Th — thienyl,

ThDP ____ thiamine diphosphate,

TMS — trimethylsilyl,

TTSCP — Thermus thermophilus steroid carrier protein,

%Vbur — percentage buried volume,

Xphos — 2-dicyclohexylphosphino-2',4',6'-triisopropylbi phenyl.

References

1.
Simmons–Smith Cyclopropanation: A Multifaceted Synthetic Protocol toward the Synthesis of Natural Products and Drugs: A Review
Munir R., Zahoor A.F., Javed S., Parveen B., Mansha A., Irfan A., Khan S.G., Irfan A., Kotwica-Mojzych K., Mojzych M.
Molecules, 2023
2.
Trends in the Diels–Alder reaction in polymer chemistry
Briou B., Améduri B., Boutevin B.
Chemical Society Reviews, 2021
3.
Fukuyama reduction, Fukuyama coupling and Fukuyama–Mitsunobu alkylation: recent developments and synthetic applications
Sikandar S., Zahoor A.F., Naheed S., Parveen B., Ali K.G., Akhtar R.
Molecular Diversity, 2021
7.
The Thiazolium-Catalyzed Sila-Stetter Reaction:  Conjugate Addition of Acylsilanes to Unsaturated Esters and Ketones
Mattson A.E., Bharadwaj A.R., Scheidt K.A.
Journal of the American Chemical Society, 2004
8.
Catalytic Asymmetric Intermolecular Stetter Reaction of Glyoxamides with Alkylidenemalonates
Liu Q., Perreault S., Rovis T.
Journal of the American Chemical Society, 2008
9.
Catalytic Activation of Carbohydrates as Formaldehyde Equivalents for Stetter Reaction with Enones
Zhang J., Xing C., Tiwari B., Chi Y.R.
Journal of the American Chemical Society, 2013
12.
Scope of the Asymmetric Intramolecular Stetter Reaction Catalyzed by Chiral Nucleophilic Triazolinylidene Carbenes
13.
New Developments in the Asymmetric Stetter Reaction
Christmann M.
Angewandte Chemie - International Edition, 2005
17.
Enantioselective N‐Heterocyclic Carbene Catalysis that Exploits Imine Umpolung
Fernando J.E., Nakano Y., Zhang C., Lupton D.W.
Angewandte Chemie, 2019
19.
The First Asymmetric IntramolecularStetter Reaction. Preliminary Communication
Enders D., Breuer K., Runsink J., Teles J.H.
Helvetica Chimica Acta, 1996
20.
A Highly Enantioselective Catalytic Intramolecular Stetter Reaction
Kerr M.S., Read de Alaniz J., Rovis T.
Journal of the American Chemical Society, 2002
21.
D.Enders, B.Bockstiegel, H.Dyker, U.Jegelka, H.Kipphardt, D.Kownatka, H.Kuhlmann, D.Mannes, J.Tiebes, D.Papadopulos. DECHEMA-Monographie, 129, 209 (1993)
24.
Sharpless Asymmetric Dihydroxylation: An Impressive Gadget for the Synthesis of Natural Products: A Review
Mushtaq A., Zahoor A.F., Bilal M., Hussain S.M., Irfan M., Akhtar R., Irfan A., Kotwica-Mojzych K., Mojzych M.
Molecules, 2023
26.
Steglich esterification: A versatile synthetic approach toward the synthesis of natural products, their analogues/derivatives
Munawar S., Zahoor A.F., Hussain S.M., Ahmad S., Mansha A., Parveen B., Ali K.G., Irfan A.
Heliyon, 2024
27.
Structure-Based Virtual Screening of Furan-1,3,4-Oxadiazole Tethered N-phenylacetamide Derivatives as Novel Class of hTYR and hTYRP1 Inhibitors
Irfan A., Faisal S., Ahmad S., Al-Hussain S.A., Javed S., Zahoor A.F., Parveen B., Zaki M.E.
Pharmaceuticals, 2023
28.
Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds
Li Petri G., Raimondi M.V., Spanò V., Holl R., Barraja P., Montalbano A.
Topics in Current Chemistry, 2021
29.
BTEAC Catalyzed Ultrasonic-Assisted Synthesis of Bromobenzofuran-Oxadiazoles: Unravelling Anti-HepG-2 Cancer Therapeutic Potential through In Vitro and In Silico Studies
Irfan A., Zahoor A.F., Rasul A., Al-Hussain S.A., Faisal S., Ahmad S., Noor R., Muhammed M.T., Zaki M.E.
International Journal of Molecular Sciences, 2023
33.
A stereocontrolled total synthesis of (.+-.)-hirsutic acid C
Trost B.M., Shuey C.D., DiNinno F.
Journal of the American Chemical Society, 1979
36.
The convergent synthesis of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase
Baumann K.L., Butler D.E., Deering C.F., Mennen K.E., Millar A., Nanninga T.N., Palmer C.W., Roth B.D.
Tetrahedron Letters, 1992
37.
Stetter Reaction in Room Temperature Ionic Liquids and Application to the Synthesis of Haloperidol
Anjaiah S., Chandrasekhar S., Grée R.
Advanced Synthesis and Catalysis, 2004
38.
Patent US 12/065,555, 2009
39.
Recent Advances in Stetter Reaction and Related Chemistry: An update
Heravi M.M., Zadsirjan V., Kafshdarzadeh K., Amiri Z.
Asian Journal of Organic Chemistry, 2020
41.
The green chemistry paradigm in modern organic synthesis
Zlotin S.G., Egorova K.S., Ananikov V.P., Akulov A.A., Varaksin M.V., Chupakhin O.N., Charushin V.N., Bryliakov K.P., Averin A.D., Beletskaya I.P., Dolengovski E.L., Budnikova Y.H., Sinyashin O.G., Gafurov Z.N., Kantyukov A.O., et. al.
Russian Chemical Reviews, 2023
44.
Bio-inspired NHC-organocatalyzed Stetter reaction in aqueous conditions
Debiais M., Hamoud A., Drain R., Barthélémy P., Desvergnes V.
RSC Advances, 2020
46.
Intramolecular Stereoselective Stetter Reaction Catalyzed by Benzaldehyde Lyase
Chen X., Wang Z., Lou Y., Peng Y., Zhu Q., Xu J., Wu Q.
Angewandte Chemie, 2021
47.
Installation of an organocatalyst into a protein scaffold creates an artificial Stetterase
MacAulay A., Klemencic E., Brewster R.C., Ünal S.M., Notari E., Wood C.W., Jarvis A.G., Campopiano D.J.
Chemical Communications, 2024
48.
Facile Synthesis of γ‐Ketonitriles in Water via C(sp 2 )–H Activation of Aromatic Aldehydes over Cu@g‐C 3 N 4 under Visible‐Light
Rai V.K., Verma F., Bhardiya S.R., Sheshma H., Rai A., Singh M.
European Journal of Organic Chemistry, 2020
49.
Transition Metal Catalyzed Hiyama Cross-Coupling: Recent Methodology Developments and Synthetic Applications
Noor R., Zahoor A.F., Irfan M., Hussain S.M., Ahmad S., Irfan A., Kotwica-Mojzych K., Mojzych M.
Molecules, 2022
50.
Benzocyclobutenone synthesis exploiting acylsilanes as photofunctional directing groups
Pilkington R.L., Ross H.J., Atkin L., Priebbenow D.L.
Chemical Science, 2024
53.
N‐Heterocyclic Carbene Acyl Anion Organocatalysis by Ball‐Milling
Nicholson W.I., Seastram A.C., Iqbal S.A., Reed‐Berendt B.G., Morrill L.C., Browne D.L.
ChemSusChem, 2019
56.
Synthesis of [1‐ 13 C‐5‐ 12 C]‐alpha‐ketoglutarate enables noninvasive detection of 2‐hydroxyglutarate
Miura N., Mushti C., Sail D., AbuSalim J.E., Yamamoto K., Brender J.R., Seki T., AbuSalim D.I., Matsumoto S., Camphausen K.A., Krishna M.C., Swenson R.E., Kesarwala A.H.
NMR in Biomedicine, 2021
57.
Synthetic strategies toward the synthesis of polyphenolic natural products: Pauciflorol F and isopaucifloral F: A review
59.
Applications of Bioisosteres in the Design of Biologically Active Compounds
Meanwell N.A.
Journal of Agricultural and Food Chemistry, 2023
66.
Total Synthesis of Iheyamine A via the Cyanide-Catalyzed Imino-Stetter Reaction
67.
Antirhine, a new indole alkaloid from Antirhea putaminosa(F.v.Muell.) Bail.
Johns S.R., Lamberton J.A., Occolowitz J.L.
Chemical Communications (London), 1967
68.
Aspidosperma de Guyane: Alcaloïdes de Aspidosperma marcgravianum
Robert G.M., Ahond A., Poupat C., Potier P., Jollès C., Jousselin A., Jacquemin H.
Journal of Natural Products, 1983
69.
Indole Alkaloids from Antirhea portoricensis
Weniger B., Anton R., Varea T., Quirion J., Bastida J., Garcia R.
Journal of Natural Products, 1994
70.
Synthesis of (.+-.)-antirhine from (.+-.)-norcamphor
Takano S., Takahashi M., Ogasawara K.
Journal of the American Chemical Society, 1980
71.
A total synthesis of (-)-antirhine.
SUZUKI T., SATO E., UNNO K., KAMETANI T.
Chemical and Pharmaceutical Bulletin, 2011
72.
A highly enantioselective synthesis of (−)-antirhine by chemo-enzymatic approach
Danieli B., Lesma G., Mauro M., Palmisano G., Passarella D.
Tetrahedron, 1994
74.
Stereoselective synthesis of (.+-.)-dihydroantirhine
Ficini J., Guingant A., D'Angelo J.
Journal of the American Chemical Society, 1979
77.
A Stereodivergent Strategy for Total Syntheses of Antirhine Alkaloids
Park E., Bae C., Cho C., Cheon C.
Journal of Organic Chemistry, 2021
78.
Hinckdentine-A : a novel alkaloid from the marine bryozoan Hincksinoflustra denticulata
Blackman A.J., Hambley T.W., Picker K., Taylor W.C., Thirasasana N.
Tetrahedron Letters, 1987
79.
First Total Synthesis of Hinckdentine A
Higuchi K., Sato Y., Tsuchimochi M., Sugiura K., Hatori M., Kawasaki T.
Organic Letters, 2008
80.
Enantioselective Total Synthesis of (+)-Hinckdentine A via a Catalytic Dearomatization Approach
Douki K., Ono H., Taniguchi T., Shimokawa J., Kitamura M., Fukuyama T.
Journal of the American Chemical Society, 2016
82.
Synthesis of 8-Desbromohinckdentine A1
Liu Y., McWhorter W.W.
Journal of the American Chemical Society, 2003
83.
Total Synthesis of Hinckdentine A
Jeon J., Lee S.E., Cheon C.
Organic Letters, 2021
84.
Orthoscuticellines A–E, β-Carboline Alkaloids from the Bryozoan Orthoscuticella ventricosa Collected in Australia
Kleks G., Duffy S., Lucantoni L., Avery V.M., Carroll A.R.
Journal of Natural Products, 2020
85.
β-carboline alkaloids in Picrasma quassioides and their chemotaxonomic significance
Han J., Lv T., Song S., Huang X.
Biochemical Systematics and Ecology, 2023
89.
New Cytotoxic β-Carboline Alkaloids from the Marine Bryozoan, Cribricellina cribraria
Prinsep M.R., Blunt J.W., Munro M.H.
Journal of Natural Products, 1991
90.
Targeting cell cycle by β-carboline alkaloids in vitro: Novel therapeutic prospects for the treatment of cancer
Ahmad I., Fakhri S., Khan H., Jeandet P., Aschner M., Yu Z.
Chemico-Biological Interactions, 2020
92.
Stemoninines from the Roots of Stemona tuberosa
Lin L., Zhong Q., Cheng T., Tang C., Ke C., Lin G., Ye Y.
Journal of Natural Products, 2006
93.
Strategies for the synthesis of Stemona alkaloids: an update
Olivier W.J., Henneveld J.S., Smith J.A., Hawkins B.C., Bissember A.C.
Natural Product Reports, 2022
94.
Tailored Synthesis of Skeletally Diverse Stemona Alkaloids through Chemoselective Dyotropic Rearrangements of β‐Lactones
Guo Z., Bao R., Li Y., Li Y., Zhang J., Tang Y.
Angewandte Chemie - International Edition, 2021
96.
Asymmetric Total Synthesis of Four Stemona Alkaloids
Wang X., Yin G., Wang Y., Zeng Y., Peng Y., Zhang X., Peng X., Wang Z.
Organic Letters, 2023
97.
Photochemically Enabled Total Syntheses of Stemoamide Alkaloids
Akkawi N.R., Nicewicz D.A.
Journal of the American Chemical Society, 2025
99.
New and Bioactive Sesquiterpenes from Schisandra sphenanthera
Mendbayar K., Lo I., Liaw C., Lin Y., Fazary A.E., Kuo Y., Wang H., Chiang B.H., Liou S., Shen Y.
Helvetica Chimica Acta, 2011
100.
Andersen N.H., Brady S.F., Harris C.M., Harris T.M., Hecker E., Hindley K.B., McGregor D.N., Marshall J.A., Roberts J.C., Schmidt R., Schrauzer G.N., Swan G.A., Tamm C., Wagner H., Winterfeldt E., et. al.
1974
101.
Synthesis of (-)-acorone and related spirocyclic sesquiterpenes
Marx J.N., Norman L.R.
Journal of Organic Chemistry, 1975
102.
New stereocontrolled approach to spirosesquiterpenes. Synthesis of acorenone B
Trost B.M., Hiroi K., Holy N.
Journal of the American Chemical Society, 1975
103.
Total synthesis of (.+-.)-acorone
McCrae D.A., Dolby L.
Journal of Organic Chemistry, 1977
104.
S.Kurosawa, M.Bando, K.Mori. Eur. J. Org. Chem., 2001, 4395 (2001); doi.org/10.1002/1099-0690(200112)2001:23%3C4395::AID-EJOC4395%3E3.0.CO;2-Q
107.
Calphostins, novel and specific inhibitors of protein kinase C. II. Chemical structures.
109.
Optically Active Total Synthesis of Calphostin D
Hauser F.M., Sengupta D., Corlett S.A.
Journal of Organic Chemistry, 1994
110.
Carbene Complexes in the Synthesis of Complex Natural Products:  Total Synthesis of the Calphostins
Merlic C.A., Aldrich C.C., Albaneze-Walker J., Saghatelian A.
Journal of the American Chemical Society, 2000
111.
Wei-Shin C., Yuan-Teng C., Xiang-Yi W., Friedrichs E., Puff H., Breitmaier E.
1981
112.
Perylenequinone Natural Products: Total Synthesis of Hypocrellin A
O’Brien E.M., Morgan B.J., Mulrooney C.A., Carroll P.J., Kozlowski M.C.
Journal of Organic Chemistry, 2009
114.
Naturally Occurring Partially Reduced Perylenequinones from Fungi
Geris R., Pinho M.A., Boffo E.F., Simpson T.J.
Journal of Natural Products, 2022
115.
Synthesis of the Altertoxin I Framework
Gutsche M., Pfaff D., Podlech J.
European Journal of Organic Chemistry, 2023
116.
HIV-Inhibitory and Cytotoxic Oligostilbenes from the Leaves of Hopea malibato
Dai J., Hallock Y.F., Cardellina J.H., Boyd M.R.
Journal of Natural Products, 1998
117.
Shoreaphenol, a polyphenol from Shorea robusta
Patra A., Dey A.K., Kundu A.B., Saraswathy A., Purushothaman K.K.
Phytochemistry, 1992
118.
Hopeafuran and a C-Glucosyl Resveratrol Isolated from Stem Wood of Hopea utilis.
TANAKA T., ITO T., IDO Y., NAKAYA K., IINUMA M., CHELLADURAI V.
Chemical and Pharmaceutical Bulletin, 2002
119.
Synthetic Approach to Malibatol  A
Kraus G.A., Kim I.
Organic Letters, 2003
120.
C.-S.Yao, L.-X.Zhou, M.Lin. Chem. Pharm. Bull., 52, 238 (2004)
121.
Biomimic transformation of resveratrol
Takaya Y., Terashima K., Ito J., He Y., Tateoka M., Yamaguchi N., Niwa M.
Tetrahedron, 2005
122.
Regio- and Stereoselective Biomimetic Synthesis of Oligostilbenoid Dimers from Resveratrol Analogues: Influence of the Solvent, Oxidant, and Substitution
Velu S., Buniyamin I., Ching L., Feroz F., Noorbatcha I., Gee L., Awang K., Wahab I., Weber J.
Chemistry - A European Journal, 2008
124.
LC-MS-Guided Isolation of Penicilfuranone A: A New Antifibrotic Furancarboxylic Acid from the Plant Endophytic Fungus Penicillium sp. sh18
Wang W., Li A., Yan B., Niu S., Tang J., Li X., Du X., Challis G.L., Che Y., Sun H., Pu J.
Journal of Natural Products, 2015
125.
Molecular Basis for the Biosynthesis of an Unusual Chain-Fused Polyketide, Gregatin A
Wang W., Wang H., Du L., Li M., Chen L., Yu J., Cheng G., Zhan M., Hu Q., Zhang L., Yao M., Matsuda Y.
Journal of the American Chemical Society, 2020
126.
Asymmetric total synthesis of penicilfuranone A through an NHC-catalyzed umpolung strategy
Ding Y., Long X., Zhang J., Qu C., Wang P., Yang X., Puno P., Deng J.
Chemical Science, 2025
128.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation–Associated Advanced Ovarian Cancer
Balasubramaniam S., Beaver J.A., Horton S., Fernandes L.L., Tang S., Horne H.N., Liu J., Liu C., Schrieber S.J., Yu J., Song P., Pierce W., Robertson K.J., Palmby T.R., Chiu H., et. al.
Clinical Cancer Research, 2017
129.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate Cancer
Anscher M.S., Chang E., Gao X., Gong Y., Weinstock C., Bloomquist E., Adeniyi O., Charlab R., Zimmerman S., Serlemitsos-Day M., Ning Y.M., Mayrosh R., Fuller B., Trentacosti A.M., Gallagher P., et. al.
Oncologist, 2020
130.
Multkilogram Scale-Up of a Reductive Alkylation Route to a Novel PARP Inhibitor
Gillmore A.T., Badland M., Crook C.L., Castro N.M., Critcher D.J., Fussell S.J., Jones K.J., Jones M.C., Kougoulos E., Mathew J.S., McMillan L., Pearce J.E., Rawlinson F.L., Sherlock A.E., Walton R., et. al.
Organic Process Research and Development, 2012
133.
Total Synthesis of Rucaparib
Park J., Cheon C.
Journal of Organic Chemistry, 2022
135.
Practical and Efficient Approach to Scalable Synthesis of Rucaparib
Park J., Cheon C.
Organic Process Research and Development, 2024
136.
Synthesis of a Pinacol Boronate Precursor for [18F]Rucaparib Radiosynthesis
Seo J., Park J., Cheon C.
Asian Journal of Organic Chemistry, 2023
137.
Selective toxicity of the tricyclic thiophene NSC 652287 in renal carcinoma cell lines
Rivera M.I., Stinson S.F., Vistica D.T., Jorden J.L., Kenney S., Sausville E.A.
Biochemical Pharmacology, 1999
138.
Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors
Issaeva N., Bozko P., Enge M., Protopopova M., Verhoef L.G., Masucci M., Pramanik A., Selivanova G.
Nature Medicine, 2004
140.
Synthetic Strategy of RITA* Drug Enabled by N‐Heterocylic Carbene via 1,4‐Synthon Formation and DFT Studies*RITA‐Reactivating p53 and Inducing Tumor Apoptosis.